Global Viral Vectors and Plasmid DNA Manufacturing Market 2017 Size, Share, Forecasts to 2022

Published On: Aug 2017

Format: PDF

Publisher: QY Research

Pages: 125

Report ID: 107537

This report studies Viral Vectors and Plasmid DNA Manufacturing in Global market, especially in North America, Europe, China, Japan, Latin America and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
Addgene
ATCC
DSMZ
NBRP
BioVector NTCC
OriGene
Invivogen
Waisman Biomanufacturing
NTC
BioReliance
Biovian
Brammer Bio
Cobra Biologics
FinVector
FUJIFILM Diosynth Biotechnologies
Lonza
MassBiologics
MolMed
Oxford BioMedica
Sanofi

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Viral Vectors and Plasmid DNA Manufacturing in these regions, from 2011 to 2021 (forecast), like
North America
China
Europe
Japan
Latin America
India
Row

Split by Product Types, with production, revenue, price, market share and growth rate of each type, can be divided into
Viral Vectors
Lentiviruses
Adenoviruses
Adeno-Associated Viruses
Others
Plasmid DNA
Conjugative plasmids
Non-conjugative plasmids
Split by applications, this report focuses on consumption, market share and growth rate of Viral Vectors and Plasmid DNA Manufacturing in each application, can be divided into
Gene Therapy
Vaccination
Immunotherapy
Formulation development
Others


Table of Contents

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2017
1 Viral Vectors and Plasmid DNA Manufacturing Market Overview
1.1 Product Overview and Scope of Viral Vectors and Plasmid DNA Manufacturing
1.2 Viral Vectors and Plasmid DNA Manufacturing Segment by Types
1.2.1 Global Production Market Share of Viral Vectors and Plasmid DNA Manufacturing by Types in 2016
1.2.2 Viral Vectors
1.2.2.1 Lentiviruses
1.2.2.2 Adenoviruses
1.2.2.3 Adeno-Associated Viruses
1.2.2.4 Others
1.2.3 Plasmid DNA
1.2.3.1 Conjugative plasmids
1.2.3.2 Non-conjugative plasmids
1.3 Viral Vectors and Plasmid DNA Manufacturing Segment by Applications
1.3.1 Viral Vectors and Plasmid DNA Manufacturing Consumption Market Share by Applications in 2016
1.3.2 Gene Therapy
1.3.3 Vaccination
1.3.4 Immunotherapy
1.3.5 Formulation development
1.3.6 Others
1.4 Viral Vectors and Plasmid DNA Manufacturing Market by Regions
1.4.1North America Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Latin America Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Row Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Viral Vectors and Plasmid DNA Manufacturing (2012-2022)
2 Global Viral Vectors and Plasmid DNA Manufacturing Market Competition by Manufacturers
2.1 Global Viral Vectors and Plasmid DNA Manufacturing Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Viral Vectors and Plasmid DNA Manufacturing Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Viral Vectors and Plasmid DNA Manufacturing Manufacturing Base Distribution, Sales Area, Product Types
2.5 Viral Vectors and Plasmid DNA Manufacturing Market Competitive Situation and Trends
2.5.1 Viral Vectors and Plasmid DNA Manufacturing Market Concentration Rate
2.5.2 Viral Vectors and Plasmid DNA Manufacturing Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Viral Vectors and Plasmid DNA Manufacturing Capacity, Production, Revenue (Value) by Regions (2012-2017)
3.1 Global Viral Vectors and Plasmid DNA Manufacturing Capacity and Market Share by Regions (2012-2017)
3.2 Global Viral Vectors and Plasmid DNA Manufacturing Production and Market Share by Regions (2012-2017)
3.3 Global Viral Vectors and Plasmid DNA Manufacturing Revenue (Value) and Market Share by Regions (2012-2017)
3.4 Global Viral Vectors and Plasmid DNA Manufacturing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5North America Viral Vectors and Plasmid DNA Manufacturing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Viral Vectors and Plasmid DNA Manufacturing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Viral Vectors and Plasmid DNA Manufacturing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Viral Vectors and Plasmid DNA Manufacturing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Latin America Viral Vectors and Plasmid DNA Manufacturing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Viral Vectors and Plasmid DNA Manufacturing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.11 Row Viral Vectors and Plasmid DNA Manufacturing Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
4 Global Viral Vectors and Plasmid DNA Manufacturing Supply (Production), Consumption, Export, Import by Regions (2012-2017)
4.1 Global Viral Vectors and Plasmid DNA Manufacturing Consumption by Regions (2012-2017)
4.2North America Viral Vectors and Plasmid DNA Manufacturing Production, Consumption, Export, Import by Regions (2012-2017)
4.3 Europe Viral Vectors and Plasmid DNA Manufacturing Production, Consumption, Export, Import by Regions (2012-2017)
4.4 China Viral Vectors and Plasmid DNA Manufacturing Production, Consumption, Export, Import by Regions (2012-2017)
4.5 Japan Viral Vectors and Plasmid DNA Manufacturing Production, Consumption, Export, Import by Regions (2012-2017)
4.6 Latin America Viral Vectors and Plasmid DNA Manufacturing Production, Consumption, Export, Import by Regions (2012-2017)
4.7 India Viral Vectors and Plasmid DNA Manufacturing Production, Consumption, Export, Import by Regions (2012-2017)
4.8 Row Viral Vectors and Plasmid DNA Manufacturing Production, Consumption, Export, Import by Regions (2012-2017)
5 Global Viral Vectors and Plasmid DNA Manufacturing Production, Revenue (Value), Price Trend by Types
5.1 Global Viral Vectors and Plasmid DNA Manufacturing Production and Market Share by Types (2012-2017)
5.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue and Market Share by Types (2012-2017)
5.3 Global Viral Vectors and Plasmid DNA Manufacturing Price by Type (2012-2017)
5.4 Global Viral Vectors and Plasmid DNA Manufacturing Production Growth by Type (2012-2017)
6 Global Viral Vectors and Plasmid DNA Manufacturing Market Analysis by Applications
6.1 Global Viral Vectors and Plasmid DNA Manufacturing Consumption and Market Share by Applications (2012-2017)
6.2 Global Viral Vectors and Plasmid DNA Manufacturing Consumption Growth Rate by Applications (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Viral Vectors and Plasmid DNA Manufacturing Manufacturers Profiles/Analysis
7.1 Addgene
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Viral Vectors and Plasmid DNA Manufacturing Product Types, Application and Specification
7.1.2.1 Viral Vectors
7.1.2.2 Plasmid DNA
7.1.3 Addgene Viral Vectors and Plasmid DNA Manufacturing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2 ATCC
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Viral Vectors and Plasmid DNA Manufacturing Product Types, Application and Specification
7.2.2.1 Viral Vectors
7.2.2.2 Plasmid DNA
7.2.3 ATCC Viral Vectors and Plasmid DNA Manufacturing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3 DSMZ
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Viral Vectors and Plasmid DNA Manufacturing Product Types, Application and Specification
7.3.2.1 Viral Vectors
7.3.2.2 Plasmid DNA
7.3.3 DSMZ Viral Vectors and Plasmid DNA Manufacturing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4 NBRP
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Viral Vectors and Plasmid DNA Manufacturing Product Types, Application and Specification
7.4.2.1 Viral Vectors
7.4.2.2 Plasmid DNA
7.4.3 NBRP Viral Vectors and Plasmid DNA Manufacturing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5 BioVector NTCC
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Viral Vectors and Plasmid DNA Manufacturing Product Types, Application and Specification
7.5.2.1 Viral Vectors
7.5.2.2 Plasmid DNA
7.5.3 BioVector NTCC Viral Vectors and Plasmid DNA Manufacturing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6 OriGene
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Viral Vectors and Plasmid DNA Manufacturing Product Types, Application and Specification
7.6.2.1 Viral Vectors
7.6.2.2 Plasmid DNA
7.6.3 OriGene Viral Vectors and Plasmid DNA Manufacturing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7 Invivogen
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Viral Vectors and Plasmid DNA Manufacturing Product Types, Application and Specification
7.7.2.1 Viral Vectors
7.7.2.2 Plasmid DNA
7.7.3 Invivogen Viral Vectors and Plasmid DNA Manufacturing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8 Waisman Biomanufacturing
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Viral Vectors and Plasmid DNA Manufacturing Product Types, Application and Specification
7.8.2.1 Viral Vectors
7.8.2.2 Plasmid DNA
7.8.3 Waisman Biomanufacturing Viral Vectors and Plasmid DNA Manufacturing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.9 NTC
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Viral Vectors and Plasmid DNA Manufacturing Product Types, Application and Specification
7.9.2.1 Viral Vectors
7.9.2.2 Plasmid DNA
7.9.3 NTC Viral Vectors and Plasmid DNA Manufacturing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.10 BioReliance
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Viral Vectors and Plasmid DNA Manufacturing Product Types, Application and Specification
7.10.2.1 Viral Vectors
7.10.2.2 Plasmid DNA
7.10.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
7.11 Biovian
7.12 Brammer Bio
7.13 Cobra Biologics
7.14 FinVector
7.15 FUJIFILM Diosynth Biotechnologies
7.16 Lonza
7.17 MassBiologics
7.18 MolMed
7.19 Oxford BioMedica
7.20 Sanofi
8 Viral Vectors and Plasmid DNA Manufacturing Manufacturing Cost Analysis
8.1 Viral Vectors and Plasmid DNA Manufacturing Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Viral Vectors and Plasmid DNA Manufacturing
9 Vaccination Chain, Sourcing Strategy and Downstream Buyers
9.1 Viral Vectors and Plasmid DNA Manufacturing Vaccination Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Viral Vectors and Plasmid DNA Manufacturing Major Manufacturers in 2016
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast (2017-2022)
12.1 Global Viral Vectors and Plasmid DNA Manufacturing Capacity, Production, Revenue Forecast (2017-2022)
12.2 Global Viral Vectors and Plasmid DNA Manufacturing Production, Consumption Forecast by Regions (2017-2022)
12.3 Global Viral Vectors and Plasmid DNA Manufacturing Production Forecast by Type (2017-2022)
12.4 Global Viral Vectors and Plasmid DNA Manufacturing Consumption Forecast by Application (2017-2022)
12.5 Viral Vectors and Plasmid DNA Manufacturing Price Forecast (2017-2022)
13 Research Findings and Conclusion
14 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer